About this episode

Troy Wilson discusses his career in biotech and the development of targeted cancer drugs.

Troy Wilson, CEO of San Diego-based Kura Oncology, on his career in biotech and developing targeted cancer drugs.

More episodes of The Long Run with Luke Timmerman

• Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With · July 14, 2026 · 1h 8m
• Ep203: Sri Kosuri on Small Molecule Correctors of Disease · June 16, 2026 · 1h 12m

Explore listener stats, chart rankings, contacts and more on the The Long Run with Luke Timmerman podcast page.